|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.00 EUR | -1.48% |
|
-6.10% | +13.51% |
| 02-16 | LANXESS AG : UBS reiterates its Sell rating | ZD |
| 02-10 | Goldman Turns More Optimistic for Chemicals Sector - Recovery Gains Momentum | DP |
Company Valuation: LANXESS AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,419 | 4,701 | 3,255 | 2,450 | 2,036 | 1,727 | 1,727 | - |
| Change | - | -13.25% | -30.76% | -24.75% | -16.88% | -15.18% | 0% | - |
| Enterprise Value (EV) 1 | 6,431 | 6,946 | 7,069 | 4,948 | 4,417 | 3,759 | 3,694 | 3,614 |
| Change | - | 8.01% | 1.77% | -30.01% | -10.72% | -14.9% | -1.72% | -2.17% |
| P/E ratio | 6.14x | 17.6x | 17.7x | 5.53x | -11.5x | -7.09x | -12.2x | -34.4x |
| PBR | 1.83x | 1.25x | 0.74x | 0.54x | 0.44x | 0.4x | 0.41x | 0.42x |
| PEG | - | -0.3x | -0.6x | 0x | 0x | -0.2x | 0.3x | 0.5x |
| Capitalization / Revenue | 0.89x | 0.62x | 0.4x | 0.36x | 0.32x | 0.3x | 0.3x | 0.29x |
| EV / Revenue | 1.05x | 0.92x | 0.87x | 0.74x | 0.69x | 0.66x | 0.65x | 0.61x |
| EV / EBITDA | 7.46x | 6.88x | 7.6x | 9.66x | 7.19x | 7.4x | 7.12x | 6.17x |
| EV / EBIT | 16.2x | 13.9x | 18.2x | -93.4x | 83.3x | -275x | 485x | 57.7x |
| EV / FCF | 49.9x | -174x | -28.5x | 9.66x | 23.5x | 92.2x | 17x | 21.2x |
| FCF Yield | 2.01% | -0.58% | -3.51% | 10.3% | 4.26% | 1.08% | 5.87% | 4.72% |
| Dividend per Share 2 | 1 | 1.05 | 1.05 | 0.1 | 0.1 | 0.1002 | 0.1048 | 0.2527 |
| Rate of return | 1.59% | 1.93% | 2.79% | 0.35% | 0.42% | 0.5% | 0.52% | 1.26% |
| EPS 2 | 10.22 | 3.09 | 2.13 | 5.13 | -2.05 | -2.819 | -1.643 | -0.5821 |
| Distribution rate | 9.78% | 34% | 49.3% | 1.95% | -4.88% | -3.55% | -6.38% | -43.4% |
| Net sales 1 | 6,104 | 7,557 | 8,088 | 6,714 | 6,366 | 5,738 | 5,719 | 5,900 |
| EBITDA 1 | 862 | 1,010 | 930 | 512 | 614 | 507.9 | 519.2 | 585.5 |
| EBIT 1 | 396 | 500 | 389 | -53 | 53 | -13.69 | 7.623 | 62.66 |
| Net income 1 | 885 | 267 | 250 | 443 | -177 | -254.3 | -150.3 | -64.16 |
| Net Debt 1 | 1,012 | 2,245 | 3,814 | 2,498 | 2,381 | 2,032 | 1,967 | 1,887 |
| Reference price 2 | 62.76 | 54.50 | 37.70 | 28.37 | 23.58 | 20.00 | 20.00 | 20.00 |
| Nbr of stocks (in thousands) | 86,346 | 86,258 | 86,346 | 86,346 | 86,346 | 86,346 | 86,346 | - |
| Announcement Date | 11/03/21 | 11/03/22 | 15/03/23 | 14/03/24 | 19/03/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.2x | 0.66x | 7.45x | 0.49% | 2.07B | |
| 20.62x | 3.39x | 9.54x | 1.98% | 65.52B | |
| 26.31x | 1.05x | 9.56x | 4.44% | 52.71B | |
| 62.66x | 10.25x | 43.11x | 0.89% | 16.79B | |
| 16.78x | 1.02x | 7.41x | 2.35% | 15.28B | |
| 11.8x | 0.76x | 6.7x | 2.86% | 9.89B | |
| 20.8x | 0.7x | 8.21x | 3.26% | 9.81B | |
| 32.99x | 1.58x | 8.03x | 2.02% | 9.5B | |
| 42.88x | 5.32x | 24.02x | 0.31% | 8.97B | |
| 19.7x | 0.83x | 6.26x | 2.08% | 6.24B | |
| Average | 24.73x | 2.56x | 13.03x | 2.07% | 19.68B | |
| Weighted average by Cap. | 26.29x | 2.79x | 12.50x | 2.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- LXS Stock
- Valuation LANXESS AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition